Pramoxine (Anusol Pain Relief)
Pramoxine
Mdi Healthcare CC
Registration
- Applicant
- Mdi Healthcare CC
- Registrations
- 1
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Anusol pain relief ointment EACH 1,0 g OINTMENT CONTAINS PRAMOXINE HYDROCHLORIDE 10,0 mg | Ointment | T0065T/11.8/0065 | Registered | S1 | None |
Regulatory status
Where S1 sits on the scale
Sold by a pharmacist, no doctor's prescription needed.
Schedule 1 medicines are normally sold by a pharmacist, or by a supervised pharmacist intern or assistant, without a doctor's visit; a veterinarian, or a licensed dispensing doctor, dentist or nurse prescriber, may also supply them. A nurse or other non-doctor prescriber may only prescribe the specific substances the Schedule names for that purpose, and may only dispense them if licensed to do so. A child under 12 may only be sold one of these medicines on a prescription, or on a written order that names the purpose and carries a signature the seller recognises.
Schedule S1, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist, or a supervised pharmacist intern or assistant; manufacturers and wholesalers supplying people who may lawfully possess it; a veterinarian, who may prescribe, compound or dispense it; a medical practitioner or dentist, who may prescribe it, and may compound or dispense it only if licensed under section 22C(1)(a); a nurse or other registered non-doctor prescriber, who may prescribe only the Scheduled substances the Schedule identifies for that purpose, and dispense them if licensed to do so; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Pramoxine hydrochloride
S1: Pramoxine
Consolidated Schedules 06 July 2026, line 1029
Pharmacological class: Suppositories and anal ointments. (class 11.8)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
4-[3-(4-Butoxyphenoxy)propyl]morpholine
Drag to rotate. Structure from PubChem CID 4886.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.